BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32703310)

  • 21. Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021.
    Rosic T; Kolla G; Leece P; Kitchen S; Gomes T
    JAMA Netw Open; 2023 Jul; 6(7):e2321947. PubMed ID: 37410463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid agonist therapy and mortality among First Nations and other residents with concurrent alcohol use disorder in British Columbia, Canada: A population-based cohort study.
    Barker B; Min JE; Homayra F; Piske M; Sabeti S; Meilleur L; Nosyk B; Wieman N
    Drug Alcohol Depend; 2023 Sep; 250():110908. PubMed ID: 37544037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study.
    Palis H; Zhao B; Young P; Korchinski M; Greiner L; Nicholls T; Slaunwhite A
    Subst Abuse Treat Prev Policy; 2022 Nov; 17(1):77. PubMed ID: 36434706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use.
    Corace K; Thavorn K; Suschinsky K; Willows M; Leece P; Kahan M; Nijmeh L; Aubin N; Roach M; Garner G; Saskin R; Kim E; Rice D; Taha S; Garber G; Hutton B
    JAMA Netw Open; 2023 Nov; 6(11):e2344528. PubMed ID: 37991762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness.
    Fine DR; Lewis E; Weinstock K; Wright J; Gaeta JM; Baggett TP
    JAMA Netw Open; 2021 Mar; 4(3):e210477. PubMed ID: 33662132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.
    Riblet NB; Gottlieb DJ; Shiner B; Cornelius SL; Watts BV
    J Dual Diagn; 2020; 16(2):228-238. PubMed ID: 31852392
    [No Abstract]   [Full Text] [Related]  

  • 27. Quality of primary care among individuals receiving treatment for opioid use disorder.
    Spithoff S; Kiran T; Khuu W; Kahan M; Guan Q; Tadrous M; Leece P; Martins D; Gomes T
    Can Fam Physician; 2019 May; 65(5):343-351. PubMed ID: 31088874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.
    Socías ME; Wood E; Kerr T; Nolan S; Hayashi K; Nosova E; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2018 Aug; 189():90-95. PubMed ID: 29894910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of emergency department visits for opioid overdose: a population-based study.
    Hasegawa K; Brown DF; Tsugawa Y; Camargo CA
    Mayo Clin Proc; 2014 Apr; 89(4):462-71. PubMed ID: 24629443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 5 year retrospective study of emergency department use in Northwest Ontario: a measure of mental health and addictions needs.
    Matsumoto CL; O'Driscoll T; Lawrance J; Jakubow A; Madden S; Kelly L
    CJEM; 2017 Sep; 19(5):381-385. PubMed ID: 27819196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review.
    Ghabrash MF; Bahremand A; Veilleux M; Blais-Normandin G; Chicoine G; Sutra-Cole C; Kaur N; Ziegler D; Dubreucq S; Juteau LC; Lestage L; Jutras-Aswad D
    J Dual Diagn; 2020; 16(2):191-207. PubMed ID: 32089124
    [No Abstract]   [Full Text] [Related]  

  • 32. Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia.
    Jones NR; Shanahan M; Dobbins T; Degenhardt L; Montebello M; Gisev N; Larney S
    Drug Alcohol Rev; 2019 Sep; 38(6):690-698. PubMed ID: 31577058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada.
    Eibl JK; Gomes T; Martins D; Camacho X; Juurlink DN; Mamdani MM; Dhalla IA; Marsh DC
    J Addict Med; 2015; 9(6):440-6. PubMed ID: 26484843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada.
    Lau J; Scott MM; Everett K; Gomes T; Tanuseputro P; Jennings S; Bagnarol R; Zimmermann C; Isenberg SR
    CMAJ; 2024 Apr; 196(16):E547-E557. PubMed ID: 38684285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-Year Mortality After Emergency Department Visit for Nonfatal Opioid Poisoning: A Population-Based Analysis.
    Leece P; Chen C; Manson H; Orkin AM; Schwartz B; Juurlink DN; Gomes T
    Ann Emerg Med; 2020 Jan; 75(1):20-28. PubMed ID: 31561997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the Impact of Prescribed Versus Nonprescribed Benzodiazepine Use in Methadone Maintenance Therapy: Results From a Population-based Retrospective Cohort Study.
    Eibl JK; Wilton AS; Franklyn AM; Kurdyak P; Marsh DC
    J Addict Med; 2019; 13(3):182-187. PubMed ID: 30543543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of obstructive sleep apnea and opioids use on adverse health outcomes: A population study of health administrative data.
    Kendzerska T; Gomes T; Malhotra A; Gershon AS; Povitz M; McIsaac DI; Aaron SD; Chung F; Bryson GL; Talarico R; Ahmed T; Godbout M; Tanuseputro P
    PLoS One; 2022; 17(6):e0269112. PubMed ID: 35763495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study.
    Colledge-Frisby S; Jones N; Larney S; Peacock A; Lewer D; Brothers TD; Hickman M; Farrell M; Degenhardt L
    Drug Alcohol Depend; 2022 Jul; 236():109494. PubMed ID: 35605532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis.
    Ledlie S; Tadrous M; McCormack D; Campbell T; Leece P; Kleinman RA; Kolla G; Besharah J; Smoke A; Sproule B; Gomes T
    Int J Drug Policy; 2023 Aug; 118():104119. PubMed ID: 37429161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study.
    Gisev N; Bharat C; Larney S; Dobbins T; Weatherburn D; Hickman M; Farrell M; Degenhardt L
    Lancet Public Health; 2019 Jul; 4(7):e334-e342. PubMed ID: 31201133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.